Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ECIA NASDAQ:QNRX OTCMKTS:UMGP OTCMKTS:VYCO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeECIAEncision$0.25-28.0%$0.35$0.25▼$0.50$3.56M0.651,905 shs28,189 shsQNRXQuoin Pharmaceuticals$7.11+2.9%$8.47$5.01▼$54.95$4.06M1.444,580 shs1,350 shsUMGPDalton Industries$0.03$0.03$0.02▼$0.17$1.10M0.133,328 shsN/AVYCOVycor Medical$0.11-15.4%$0.12$0.04▼$0.50$4.35M-0.729,617 shs419 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceECIAEncision0.00%-27.95%-31.69%-40.48%-16.67%QNRXQuoin Pharmaceuticals+2.89%+6.76%-23.96%+14.86%-64.03%UMGPDalton Industries0.00%0.00%-5.06%-23.27%-80.65%VYCOVycor Medical-15.38%-15.38%-15.38%-27.54%+25.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationECIAEncisionN/AN/AN/AN/AN/AN/AN/AN/AQNRXQuoin Pharmaceuticals2.1405 of 5 stars0.05.00.00.03.50.81.3UMGPDalton IndustriesN/AN/AN/AN/AN/AN/AN/AN/AVYCOVycor MedicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceECIAEncision 0.00N/AN/AN/AQNRXQuoin Pharmaceuticals 0.00N/AN/AN/AUMGPDalton Industries 0.00N/AN/AN/AVYCOVycor Medical 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookECIAEncision$6.55M0.45N/AN/A$0.14 per share1.79QNRXQuoin PharmaceuticalsN/AN/AN/AN/A$35.47 per shareN/AUMGPDalton Industries$30K36.80N/AN/AN/A∞VYCOVycor Medical$1.59M2.31N/AN/A($0.11) per share-1.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateECIAEncision-$220K-$0.02N/A∞N/A-3.36%-12.75%-5.92%N/AQNRXQuoin Pharmaceuticals-$8.96M-$48.81N/AN/AN/AN/A-177.45%-91.15%N/AUMGPDalton Industries-$260K-$0.01N/A∞N/AN/AN/AN/AN/AVYCOVycor Medical-$110KN/A0.00∞N/A-6.86%N/A-11.44%8/11/2025 (Estimated)Latest UMGP, VYCO, ECIA, and QNRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025QNRXQuoin Pharmaceuticals-$6.83-$6.28+$0.55-$6.28N/AN/A7/10/2025Q4 2025ECIAEncisionN/A-$0.01N/A-$0.01N/A$1.58 million5/15/2025Q1 2025VYCOVycor MedicalN/A-$0.01N/A-$0.01N/A$0.44 million5/13/2025Q1 2025QNRXQuoin Pharmaceuticals-$3.85-$6.50-$2.65-$6.50N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthECIAEncisionN/AN/AN/AN/AN/AQNRXQuoin PharmaceuticalsN/AN/AN/AN/AN/AUMGPDalton IndustriesN/AN/AN/AN/AN/AVYCOVycor MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioECIAEncision0.111.660.72QNRXQuoin PharmaceuticalsN/A2.572.57UMGPDalton IndustriesN/AN/AN/AVYCOVycor MedicalN/A0.130.09Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipECIAEncision8.20%QNRXQuoin Pharmaceuticals8.63%UMGPDalton IndustriesN/AVYCOVycor MedicalN/AInsider OwnershipCompanyInsider OwnershipECIAEncision36.75%QNRXQuoin Pharmaceuticals13.46%UMGPDalton IndustriesN/AVYCOVycor Medical7.03%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableECIAEncision3011.88 million7.51 millionNot OptionableQNRXQuoin Pharmaceuticals4590,000509,000Not OptionableUMGPDalton Industries2436.80 millionN/ANot OptionableVYCOVycor Medical633.42 million31.07 millionNot OptionableUMGP, VYCO, ECIA, and QNRX HeadlinesRecent News About These CompaniesVycor Medical Posts 22 Percent Q2 GrowthAugust 9 at 2:38 AM | aol.comANew Study on NovaVision's NeuroEyeCoach Shows Significant Benefits for Patients in Home or Clinic SettingJuly 8, 2025 | finance.yahoo.comVYCO Vycor Medical, Inc.May 31, 2025 | seekingalpha.comVycor Medical Joins B2i Digital Venture Company Program to Build and Educate Its Investor BaseMarch 14, 2025 | finance.yahoo.comEQS-News: Vycor Medical Joins B2i Digital Venture Company Program to Build and Educate Its Investor BaseMarch 13, 2025 | markets.businessinsider.comMedical ethics articles from across Nature PortfolioOctober 22, 2024 | nature.comNBlueChew Review 2024January 17, 2024 | medicalnewstoday.comMWhat to know about bleeding hemorrhoidsDecember 19, 2023 | medicalnewstoday.comMCommon symptoms of depression: What to knowOctober 11, 2023 | medicalnewstoday.comMVycor Medical, Inc. (VYCO)January 7, 2023 | finance.yahoo.comMedical Review BoardNovember 1, 2022 | health.usnews.comMedical Scholars ProgramSeptember 12, 2022 | slu.eduSVycor Medical IncSeptember 8, 2022 | reuters.comMinnetronix commercializes its own product: a minimally invasive deep brain access portAugust 20, 2022 | medcitynews.comMViewSite Brain Access System (VBAS) for the surgical management of deep brain lesionsMay 11, 2022 | nice.org.ukNVycor Medical Year to Date Total Returns (Daily)January 2, 2022 | ycharts.comYVycor Medical Inc (VYCO)December 17, 2021 | nasdaq.comThe journal of physical chemistry. BOctober 18, 2021 | medscape.comMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesAI Infrastructure Is Exploding—Don’t Overlook CoreWeave & NebiusBy Jeffrey Neal Johnson | July 17, 2025View AI Infrastructure Is Exploding—Don’t Overlook CoreWeave & NebiusQualcomm's Next Gear: A Growth Story Wall Street Might Be MissingBy Jeffrey Neal Johnson | July 25, 2025View Qualcomm's Next Gear: A Growth Story Wall Street Might Be MissingThese 3 Stocks Could Help You Compound Wealth for Years to ComeBy Gabriel Osorio-Mazilli | July 28, 2025View These 3 Stocks Could Help You Compound Wealth for Years to ComeNebius Group: Up 385%, Analysts Say It’s Still a BargainBy Jeffrey Neal Johnson | July 10, 2025View Nebius Group: Up 385%, Analysts Say It’s Still a BargainTraders Turn Bullish on Housing Stocks Again—3 Leading the WayBy Gabriel Osorio-Mazilli | August 4, 2025View Traders Turn Bullish on Housing Stocks Again—3 Leading the WayUMGP, VYCO, ECIA, and QNRX Company DescriptionsEncision OTCMKTS:ECIA$0.25 -0.10 (-27.95%) As of 08/7/2025 03:50 PM EasternEncision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.Quoin Pharmaceuticals NASDAQ:QNRX$7.11 +0.20 (+2.89%) Closing price 08/8/2025 03:53 PM EasternExtended Trading$7.16 +0.05 (+0.77%) As of 08/8/2025 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia.Dalton Industries OTCMKTS:UMGP$0.03 0.00 (0.00%) As of 08/6/2025Universal Media Group Inc., a media company, produces and distributes media content worldwide. It produces On The Mike, a TV show that primarily include celebrity interviews, music concerts, and other events. The company was formerly known as Dalton Industries Inc. and changed its name to Universal Media Group Inc. in January 2016. Universal Media Group Inc. was founded in 1971 and is based in Boca Raton, Florida.Vycor Medical OTCMKTS:VYCO$0.11 -0.02 (-15.38%) As of 08/8/2025 03:03 PM EasternVycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement which grants for the license to provide NovaVision's products and therapies to patients and professionals in Germany, Austria and Switzerland. It primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era AppLovin’s Q2 Miss Spooks Market, But Wall Street Doubles Down DraftKings Posts Record Quarter, Eyes Profitability Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
